2.61

1.14% -0.03

After Hours: 2.60 -0.010 -0.38%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $2.61, with a volume of 73,553. It is down -1.14% in the last 24 hours and down -46.52% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$2.64

Open:

$2.68

24h Volume:

73,553

Relative Volume:

0.01

Market Cap:

$9.62M

Revenue:

$513.90K

Net Income/Loss:

$-48.50M

P/E Ratio:

-0.0932

EPS:

-28.0101

Net Cash Flow:

$-28.99M

1W Performance:

-12.71%

1M Performance:

-46.52%

6M Performance:

-64.22%

1Y Performance:

-87.42%

1-Day Range:

$2.55

$2.70

1-Week Range:

$2.54

$3.0899

52-Week Range:

$1.26

$13.54

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1096)

Industry

Medical Devices (140)

Phone

(801) 438-1036

Address

2401 S FOOTHILL DRIVE, SALT LAKE CITY

Employee

115

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	2.61	9.62M	513.90K	-48.50M	-28.99M	-28.01
ABT Abbott Laboratories	93.93	163.61B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	329.78	126.42B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.87	107.36B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.77	66.54B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	92.21	53.09B	6.30B	1.07B	1.09B	1.8406

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

Jul 10, 2026

Co-diagnostics Company Profile & Introduction - Moomoo

Jul 10, 2026

Form PRE 14A CO-DIAGNOSTICS For: 10 July By Investing.com - Investing.com South Africa

Jul 10, 2026

Co‑Diagnostics seeks shareholder approval to add 2.0M shares to equity plan | CODX SEC FilingForm PRE 14A - Stock Titan

Jul 10, 2026

Jul 08, 2026

CODX Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains AbsentNegative Surprise Momentum - dars.gov.et

Jul 02, 2026

CODX Stock Price, Quote & Chart - ChartMill

Jul 02, 2026

Jul 01, 2026

Co-Diagnostics completes studies for FDA test submission By Investing.com - Investing.com Nigeria

Jul 01, 2026

Co-Diagnostics completes studies for FDA test submission - Investing.com

Jul 01, 2026

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test - PR Newswire

Jul 01, 2026

EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform - Yahoo Finance

Jul 01, 2026

Co-Diagnostics Completes Clinical and Analytical Studies in Prep - GuruFocus

Jul 01, 2026

Jun 29, 2026

Price to earnings forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView

Jun 29, 2026

Price to earnings forward of Co-Diagnostics, Inc. – LSE:0A50 - TradingView

Jun 29, 2026

Jun 28, 2026

Enterprise value to revenue forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView

Jun 28, 2026

Price to sales forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView

Jun 28, 2026

Price to book forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView

Jun 28, 2026

Enterprise value to EBITDA forward of Co-Diagnostics, Inc. – NASDAQ:CODX - TradingView

Jun 28, 2026

Price to sales forward of Co-Diagnostics, Inc. – LSE:0A50 - TradingView

Jun 28, 2026

Jun 26, 2026

Co-Diagnostics jumps 11%, raises $3M privately - MSN

Jun 26, 2026

Jun 25, 2026

Co-Diagnostics expands mosquito testing services to 21 states By Investing.com - Investing.com Australia

Jun 25, 2026

Co-Diagnostics Expands Mosquito Abatement District Customer Base to 21 States with Four New Laboratory Installs - marketscreener.com

Jun 25, 2026

Co-Diagnostics, Inc. Actuals & Estimates (NASDAQ:CODX) - TradingView

Jun 25, 2026

Co-Diagnostics expands mosquito testing services to 21 states - Investing.com

Jun 25, 2026

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States - Barchart.com

Jun 25, 2026

Jun 24, 2026

Co-Diagnostics develops Ebola assay strategy following WHO emergency alert (CODX) - MSN

Jun 24, 2026

Jun 21, 2026

Co-Diagnostics, Inc.(NasdaqCM: CODX) added to S&P TMI Index - marketscreener.com

Jun 21, 2026

Jun 19, 2026

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line - marketscreener.com

Jun 19, 2026

Jun 18, 2026

CODX News | CO-DIAGNOSTICS INC (NASDAQ:CODX) - ChartMill

Jun 18, 2026

Co-Diagnostics, Inc. and Comira Diagnostics Host Unveiling of Future Automated Manufacturing Line - marketscreener.com

Jun 18, 2026

Co-Diagnostics hosts Saudi joint venture for manufacturing tour - Investing.com

Jun 18, 2026

Co-Diagnostics hosts Saudi joint venture for manufacturing tour By Investing.com - Investing.com Nigeria

Jun 18, 2026

Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line – Company AnnouncementFT.com - Financial Times

Jun 18, 2026

Co-Diagnostics' Saudi Venture: A High-Stakes Bet on AI and Automation - BriefGlance

Jun 18, 2026